← Back to Search

Lifestyle Changes for Stress and High Blood Pressure in Dementia Caregivers (MIM-DASH Trial)

N/A

Recruiting

Led By Kathy Wright, PhD

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 40 and older

Caregiver provides unpaid care to a PLWD at least 10 hours per week or assists with at least one instrumental activity of daily living

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 9 months

Awards & highlights

MIM-DASH Trial Summary

This trial is looking at how lifestyle changes like stress management, reducing sodium, eating fruits/veggies, and physical activity can help African American women caregivers reduce caregiving stress and hypertension. Improving lifestyle can lead to better health outcomes.

Who is the study for?

This trial is for African American women over 40 who care unpaid for a family member with Alzheimer's or related dementias, work at least 10 hours per week in caregiving, have high blood pressure treated with medication, and can access the internet. It excludes those planning to move soon, with resistant hypertension, or actively doing mindfulness/yoga.Check my eligibility

What is being tested?

The study tests caregiver training aimed at managing stress and hypertension through lifestyle changes like diet adjustments and physical activity. The goal is to improve caregivers' quality of life and reduce cardiovascular disease risk by enhancing their stress resilience.See study design

What are the potential side effects?

Since this intervention involves non-medical lifestyle changes and education rather than drugs or medical procedures, side effects are minimal but may include discomfort from new activities or dietary changes.

MIM-DASH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Select...

I provide unpaid care for someone with dementia for 10+ hours a week or help them with daily tasks.

Select...

I have high blood pressure and am taking medication for it.

MIM-DASH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Blood Pressure

Secondary outcome measures

Acceptability Scale

Change in depression will be assessed in the PHQ-9

Change is being assessed in Daily inventory of stressful events

+11 more

MIM-DASH Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MIM-DASHExperimental Treatment1 Intervention

A trained MIM provider and dietitian will deliver the MIM DASH group intervention in eight weekly 1-hour sessions via telehealth.

Group II: Attention ControlActive Control1 Intervention

A trained interventionist will deliver the Caregiver Training. Participants in this group will attend eight 1-hour group lessons via telehealth for 8 weeks. We will use Alzheimer's Association caregiver training resources on topics such as Healthy Living for Your Brain and Body: Tips from the Latest Research; Dementia Conversations: Driving, Doctors Visits, Legal and Financial Planning; and Understanding and Responding to Dementia-Related Behavior. Similar to the MIM DASH group, participants will receive educational materials so they can follow along using videoconferencing or phone.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor

830 Previous Clinical Trials

505,592 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,857 Total Patients Enrolled

Kathy Wright, PhDPrincipal InvestigatorOhio State University

1 Previous Clinical Trials

90 Total Patients Enrolled

Media Library

Caregiver Training Clinical Trial Eligibility Overview. Trial Name: NCT05721482 — N/A

High Blood Pressure Research Study Groups: MIM-DASH, Attention Control

High Blood Pressure Clinical Trial 2023: Caregiver Training Highlights & Side Effects. Trial Name: NCT05721482 — N/A

Caregiver Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05721482 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical research currently have open slots for participants?

"Data made available through clinicaltrials.gov reveals that this medical trial is enrolling patients, with the initial posting taking place on January 17th 2023 and a subsequent update following suit shortly afterwards on Janurary 31st of the same year."

Answered by AI

How many participants are currently enrolled in this clinical trial?

"Right, the data hosted on clinicaltrials.gov confirms that this study is actively enlisting participants. It was first announced on January 17th 2023 and updated recently on January 31st 2023. The trial has room for 28 patients at one particular location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Stress and Hypertension in Dementia Caregivers

Kathy D. Wright 2023. "Stress and Hypertension in Dementia Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05721482.